Kazia Therapeutics
KZIA
9 hedge funds and large institutions have $400K invested in Kazia Therapeutics in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
29% more funds holding
Funds holding: 7 → 9 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
77% less capital invested
Capital invested by funds: $1.75M → $400K (-$1.35M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TW
Transform Wealth
Greenwood Village,
Colorado
|
+$361K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$37.7K |
| 3 |
Morgan Stanley
New York
|
+$15K |
| 4 |
SPIA
Steward Partners Investment Advisory
New York
|
+$1.87K |
| 5 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
+$170 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CWM
Cornerstone Wealth Management
St. Peters,
Missouri
|
-$1.43M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$19.4K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.36K |
KZIA Hedge Fund Activity: Q3 2018 in Review
9 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q3 2018, worth a combined $400K — down 77% from $1.75M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new KZIA positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Transform Wealth, opening a new position worth an estimated $361K. The largest seller was Cornerstone Wealth Management, exiting entirely with an estimated $1.43M sold.
- 9 institutional investors held Kazia Therapeutics (KZIA) as of Q3 2018, up from 7 in Q2 2018.
- Funds reported $400K of Kazia Therapeutics stock for Q3 2018, down 77% quarter-over-quarter.
- 4 funds opened new Kazia Therapeutics positions in Q3 2018 and 2 closed out, a net change of +2 holders.
- The largest Kazia Therapeutics buyer in Q3 2018 was Transform Wealth, an estimated $361K added.
- The largest Kazia Therapeutics seller in Q3 2018 was Cornerstone Wealth Management, an estimated $1.43M sold.
Based on aggregated 13F filings for Q3 2018.